Author

Lisa Carey

Observed name: Carey, Lisa

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Observed institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

OpenAlex ID: A5121893428

Long-Term Outcome of Neoadjuvant Therapy for Locally Advanced Breast Carcinoma: Effective Clinical Downstaging Allows Breast Preservation and Predicts Outstanding Local Control and Survival

2021 · Cance, William, Graham, Mark, et al. · PubMed · 141

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer

2026 · Yi Liu, Jodi M Carter, et al. · Journal for ImmunoTherapy of Cancer · 1

The ADAPT learning cancer treatment system: ARPA-H’s initiative to revolutionize cancer therapy

2026 · Andrea H. Bild, Michelle C. Sangar, et al. · Cancer Cell · 1

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer Recurrence

2026 · Ngoc-Kim Nguyen, Anran Li, et al. · medRxiv

Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast Cancer

2026 · Frederick M. Howard, Anran Li, et al. · medRxiv

Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.

2026 · Watson, Mark, Kirshner, Jeffrey, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

Works count: 7

Citation count: 144

H-index: 1

I10-index: 1